Your browser doesn't support javascript.
loading
Mutant Isocitrate Dehydrogenase 1 Inhibitor Ivosidenib in Combination With Azacitidine for Newly Diagnosed Acute Myeloid Leukemia.
DiNardo, Courtney D; Stein, Anthony S; Stein, Eytan M; Fathi, Amir T; Frankfurt, Olga; Schuh, Andre C; Döhner, Hartmut; Martinelli, Giovanni; Patel, Prapti A; Raffoux, Emmanuel; Tan, Peter; Zeidan, Amer M; de Botton, Stéphane; Kantarjian, Hagop M; Stone, Richard M; Frattini, Mark G; Lersch, Frederik; Gong, Jing; Gianolio, Diego A; Zhang, Vickie; Franovic, Aleksandra; Fan, Bin; Goldwasser, Meredith; Daigle, Scott; Choe, Sung; Wu, Bin; Winkler, Thomas; Vyas, Paresh.
Afiliação
  • DiNardo CD; University of Texas MD Anderson Cancer Center, Houston, TX.
  • Stein AS; City of Hope Medical Center, Duarte, CA.
  • Stein EM; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Fathi AT; Massachusetts General Hospital Cancer Center, Boston, MA.
  • Frankfurt O; Northwestern University, Chicago, IL.
  • Schuh AC; Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Döhner H; Ulm University Hospital, Ulm, Germany.
  • Martinelli G; Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.
  • Patel PA; University of Texas Southwestern Medical Center, Dallas, TX.
  • Raffoux E; Hôpital Saint-Louis, Paris, France.
  • Tan P; Royal Perth Hospital, Perth, Western Australia, Australia.
  • Zeidan AM; Yale Cancer Center, New Haven, CT.
  • de Botton S; Institut Gustave Roussy, Villejuif, France.
  • Kantarjian HM; University of Texas MD Anderson Cancer Center, Houston, TX.
  • Stone RM; Dana-Farber Cancer Institute, Boston, MA.
  • Frattini MG; Bristol-Myers Squibb, Summit, NJ.
  • Lersch F; Celgene International, Boudry, Switzerland.
  • Gong J; Bristol-Myers Squibb, Summit, NJ.
  • Gianolio DA; Agios Pharmaceuticals, Cambridge, MA.
  • Zhang V; Agios Pharmaceuticals, Cambridge, MA.
  • Franovic A; Bristol-Myers Squibb, San Francisco, CA.
  • Fan B; Agios Pharmaceuticals, Cambridge, MA.
  • Goldwasser M; Agios Pharmaceuticals, Cambridge, MA.
  • Daigle S; Agios Pharmaceuticals, Cambridge, MA.
  • Choe S; Agios Pharmaceuticals, Cambridge, MA.
  • Wu B; Agios Pharmaceuticals, Cambridge, MA.
  • Winkler T; Agios Pharmaceuticals, Cambridge, MA.
  • Vyas P; University of Oxford, Oxford, United Kingdom.
J Clin Oncol ; 39(1): 57-65, 2021 01 01.
Article em En | MEDLINE | ID: mdl-33119479

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Piridinas / Azacitidina / Leucemia Mieloide Aguda / Inibidores Enzimáticos / Glicina Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Piridinas / Azacitidina / Leucemia Mieloide Aguda / Inibidores Enzimáticos / Glicina Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article